Читать книгу Anti-Aging Therapeutics Volume XVI - A4M American Academy - Страница 24

1.Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125:1147-1156. doi: 10.1161/CIRCULATIONAHA.111.047431.

2.IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, Freitag DF, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205-1213. doi: 10.1016/S0140-6736(11)61931-4.

3.Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, Hingorani AD, Casas JP, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379:1214-1224. doi: 10.1016/S0140-6736(12)60110-X.

4.Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368:651-662. doi: 10.1056/NEJMra1205406.

5.Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell. 2011;146:682-695. doi: 10.1016/j.cell.2011.07.030.

6.Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-2219. doi: 10.1056/NEJMoa1000367.

7.Estruch R, Ros E, Salas-Salvadó J, Covas MI, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-1290. doi: 10.1056/NEJMoa1200303.

8.He C, Bassik MC, Moresi V, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481:511-515. doi: 10.1038/nature10758.

9.Galluzzi L, Kroemer G. Autophagy mediates the metabolic benefits of endurance training. Circ Res. 2012;110:1276-1278. doi: 10.1161/RES.0b013e318259e70b.

10.Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011;378:1244-1253. doi: 10.1016/S0140-6736(11)60749-6.

11.Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145-1151.

12.Ben Ounis O, Elloumi M, Zouhal H, Makni E, Denguezli M, Amri M, Lac G, Tabka Z. Effect of individualized exercise training combined with diet restriction on inflammatory markers and IGF-1/IGFBP-3 in obese children. Ann Nutr Metab. 2010;56:260-266. doi: 10.1159/000275888.

13.Hubbard BP, Gomes AP, Dai H, et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 2013;339:1216-1219. doi: 10.1126/science.1231097.

14.Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32:1377-1382.

15.la Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N, Cameron DW. Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet. 2010;49:449-454. doi: 10.2165/11531820-000000000-00000.

16.Carrizzo A, Puca A, Damato A, et al. Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism. Hypertension. 2013 Jun 10. [Epub ahead of print]

17.Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-5. doi: 10.1038/nature08221.

18.Li W, Li Q, Qin L, et al. Rapamycin inhibits smooth muscle cell proliferation and obstructive arteriopathy attributable to elastin deficiency. Arterioscler Thromb Vasc Biol. 2013;33:1028-1035. doi: 10.1161/ATVBAHA.112.300407.

19.Chen HH, Mekkaoui C, Cho H, et al. Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ Cardiovasc Imaging. 2013;6:441-447. doi: 10.1161/CIRCIMAGING.112.000074.

20.Chhajed PN, Dickenmann M, Bubendorf L, Mayr M, Steiger J, Tamm M. Patterns of pulmonary complications associated with sirolimus. Respiration. 2006;73:367-374.

21.Vial T, Descotes J. Immunosuppressive drugs and cancer. Toxicology. 2003;185:229-240.

22.Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335:1638-1643.

23.Binh PNT, Soda K, Maruyama C, Kawakami M. Relationship between food polyamines and gross domestic product in association with longevity in Asian countries. Health. 2010;12:1390-1396. doi: 10.4236/health.2010.212206. Available at: http://www.scirp.org/journal/PaperDownload.aspx?paperID=32880

24.Carlquist J, Knight S, Cawthon RM, et al. Telomere length is associated with survival among patients referred for angiography. J Am Coll Cardiol. 2013;61:10_S. doi:10.1016/S0735-1097(13)61509-0

25.Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012;111:245-259. doi: 10.1161/CIRCRESAHA.111.261388.

26.Barr J, Sharma CS, Sarkar S, Wise K, Dong L, Periyakaruppan A, Ramesh GT. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol Cell Biochem. 2007;297:93-99.

27.Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341-350. doi: 10.1056/NEJMsa1211128.